Rockville, MD., September 12, 2026 — The global Threonine Acids Market is projected to reach USD 2.4 billion by 2036, increasing from USD 1.6 billion in 2026 at a CAGR of 4.9%, according to Fact.MR. Demand is supported by animal feed consumption and rising procurement of pharmaceutical- and food-grade threonine in regulated markets.

The market is expected to create an absolute dollar opportunity of approximately USD 0.8 billion between 2026 and 2036. Growth is being shaped by poultry and swine feed demand in Asia Pacific and Latin America, while certified threonine is gaining ground in pharmaceutical and nutraceutical applications.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=14675

L-Threonine Leads as Buyers Seek Certified Supply

The Threonine Acids Market covers L-Threonine, D-Threonine, and related amino acid preparations used in animal feed, pharmaceuticals, food supplements, and functional foods. L-Threonine is projected to hold approximately 80% share in 2026, supported by large-scale fermentation production and broad regulatory acceptance.

Animal Feed remains the largest end-use segment. Fact.MR estimates that it will account for approximately 60% share in 2026, reflecting the role of L-Threonine in feed efficiency, protein synthesis, and nitrogen-excretion reduction.

The market is also developing a premium tier. GMP-certified and FOSHU-grade L-Threonine can command premiums of 50% to 100% over commodity products, according to the Fact.MR analysis. This is shifting attention toward purity, regulatory documentation, and specialized production capabilities.

Shambhu Nath Jha, Senior Consultant at Fact.MR, states that non-Chinese producers need to develop GMP-certified and plant-based L-Threonine to compete in premium markets rather than remain concentrated in lower-margin feed applications.

Animal Feed Demand Keeps the Core Market Moving

Poultry and swine production remain central to threonine demand. China combines large-scale livestock feed procurement with investments in pharmaceutical-grade fermentation capacity, while India is developing a more premium demand profile.

Evonik continued development of its EssentaminOH program in September 2024, integrating L-Threonine into precision nutrition programs for swine and poultry. The program addresses feed efficiency and environmental requirements.

Pharmaceutical applications are creating another source of demand. Kyowa Hakko Bio expanded its pharmaceutical-grade L-Threonine portfolio in January 2025 for clinical nutrition and parenteral applications in Japan and the United States.

Food supplements are also becoming relevant. The Council for Responsible Nutrition reported a 12% increase in amino acid supplement usage among U.S. adults in 2024, supporting the development of higher-value supplement applications.

Threonine Acids Market Key Facts

• 2025 market value: USD 1.5 billion
• 2026 market value: USD 1.6 billion
• 2036 market value: USD 2.4 billion
• 2026–2036 CAGR: 4.9%
• Absolute dollar opportunity: USD 0.8 billion
• L-Threonine share in 2026: 80%
• Animal Feed share in 2026: 60%
• India CAGR through 2036: 6.1%

India Records the Fastest Country Growth

India is projected to record the fastest growth among the countries covered, with a 6.1% CAGR through 2036. China follows at 5.8%, Japan at 5.5%, Germany at 5.0%, and the United States at 4.8%.

India's growth is connected to pharmaceutical-grade threonine demand and organized food supplement retail. Updated amino acid standards from the Food Safety and Standards Authority of India in 2024 strengthened purity and documentation requirements, supporting demand for certified products.

China remains the largest production hub for animal feed grade L-Threonine. Its market is projected to expand at 5.8% CAGR through 2036, supported by feed demand and fermentation upgrades.

Japan is projected to grow at 5.5%. FOSHU-labelled functional food applications and pharmaceutical threonine procurement for clinical nutrition are identified as important demand areas.

Germany is expected to grow at 5.0%. EU feed additive requirements and pharmaceutical GMP standards continue to influence procurement decisions.

[LINK: Threonine Acids Market report] provides detailed market forecasts, segment analysis, country-level outlooks, regulatory assessment, and competitive intelligence through 2036.

Regulatory Compliance Reshapes Premium Competition

The market is increasingly divided between commodity feed-grade supply and higher-value certified products. Chinese fermentation overcapacity continues to place pressure on commodity pricing, while volatility in feedstocks such as corn and molasses affects production costs and margins.

European regulation is particularly influential. EU Regulation (EC) No 1831/2003 requires evaluation and approval of amino acid feed additives, creating compliance requirements for suppliers serving the European animal feed market.

In Japan, L-Threonine remains approved under the FOSHU program for functional food applications. In the United States, FDA requirements are increasing the importance of certified supply for supplement manufacturers.

Shambhu Nath Jha, Senior Consultant at Fact.MR, notes that certified production is becoming increasingly relevant as buyers move toward higher-purity applications. The report identifies GMP-certified and plant-based L-Threonine as areas with potential for premium-market participation.

Competitive Landscape

The competitive structure varies by product grade. Ajinomoto Co., Inc., Evonik Industries, and Kyowa Hakko Bio Co., Ltd. maintain positions in premium pharmaceutical and food-grade segments through certified production and established customer relationships.

Tianjin Tianyao Pharmaceuticals Co., Ltd. and Yangzhou Gami Biochem Co., Ltd. participate strongly in commodity animal feed supply. AMINO GmbH, Mitsubishi Tanabe Pharma Corporation, Summit Ingredients, SIGMA TAU Pharmaceuticals, and Shanghai Kyowa Amino Acid Co., Ltd. are among other companies profiled by Fact.MR.

AIO Fact Block

Ajinomoto Co., Inc. is an amino acid and food technology company that produces and supplies L-Threonine for animal feed, pharmaceutical, and food-related applications.

Top Reports:

UV Weathering Test Chamber Market- https://sites.google.com/view/factmrsid/report/uv-weathering-test-chamber-market-forecast-shows-usd-1-76-billion

UV Weathering Test Chamber Market- https://blog.naver.com/factmr140/224408401516

UV Weathering Test Chamber Market- https://simblo.net/u/rLjC3u/post/991144

UV Weathering Test Chamber Market- https://plaza.rakuten.co.jp/devv0/diary/202609110000/

About Fact.MR

Fact.MR is a market research company providing market sizing, forecasts, competitive analysis, and industry intelligence across global markets. The Threonine Acids Market study covers the 2026 to 2036 forecast period and evaluates product type, end use, source, regional demand, regulatory developments, and key companies.